Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP708 for Rash Acneiform
NCT05378360Phase 2Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nepidermin in acneiform eruption, sponsored by Daewoong Pharmaceutical. Started May 2022; status: completed.
02
Drugs
nepidermin
03
Conditions
acneiform eruption
Beyond the preview
Go deeper on NCT05378360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378360.